Unbelievable but true: the bacteria in our mouths and guts could be our secret weapon against severe peanut allergies!
Researchers at McMaster University have made a groundbreaking discovery, revealing that certain bacteria can reduce the risk of life-threatening allergic reactions to peanuts. This finding has the potential to revolutionize the way we approach food allergies and could lead to innovative treatments.
The mystery of why some people with similar peanut-specific antibodies react so differently has finally been unraveled. It all comes down to the unique bacteria living in our mouths and guts.
Published in the journal Cell Host & Microbe, this study sheds light on how gut bacteria break down allergenic food components, influencing our body's response to peanuts. With peanut allergies being one of the most common food allergies in Canada, affecting one in two households, this discovery could be a game-changer.
"Peanut allergies can be incredibly serious, causing breathing difficulties and, in some cases, even death. Yet, some individuals with allergies can consume small amounts without any issues. We wanted to understand this paradox, and our research has led us to the fascinating world of oral microbes," explains Liam Rondeau, a postdoctoral fellow at McMaster University's Farncombe Family Digestive Health Research Institute.
The research team analyzed saliva and upper gut samples from healthy volunteers and identified several bacterial species capable of breaking down major peanut allergens. One particular species, Rothia, stood out for its ability to prevent peanut proteins from binding with antibodies, a process that triggers allergic reactions.
Furthermore, the study found that individuals with peanut allergies who had a higher abundance of these allergen-degrading bacteria could tolerate larger amounts of peanuts before experiencing a reaction.
"The microbes in our mouth and gut are crucial for digestion, and our study suggests that some of these bacteria may play a protective role against food allergies. This newly identified link between the oral and gut microbiome and food allergy opens up exciting possibilities for future research and treatment strategies," says co-senior author Alberto Caminero Fenandez, an associate professor at McMaster's Department of Medicine.
To validate their findings, the researchers examined an external dataset of 120 children, confirming that children with higher peanut reaction thresholds had significantly more Rothia species in their microbiome. Pre-clinical experiments also showed that Rothia reduced the amount of peanut allergens entering the bloodstream, lowered the activation of immune cells that cause anaphylaxis, and resulted in milder allergic reactions.
Peanut allergy is the most common food allergy among Canadian children, and strict avoidance is currently the only recommended management strategy. However, accidental exposures are frequent, with about one-third of affected children experiencing at least one incident each year. This allergy is also the leading cause of allergy-related deaths in children, making the need for effective prevention and treatment strategies even more urgent.
The study's findings open up exciting possibilities for new approaches in allergy management, including microbial and probiotic therapies and improved oral immunotherapy strategies.
This groundbreaking research was led by a team of scientists from McMaster University's Farncombe Family Digestive Health Research Institute and Schroeder Allergy and Immunology Research Institute, in collaboration with researchers from Spain and the United States. The study received funding from various sources, including the New Frontiers in Research Fund, Natural Sciences and Engineering Research Council of Canada, and several programs of the Spanish government.
This discovery has the potential to transform the lives of individuals with peanut allergies and their families, offering hope and a glimpse into a future where food allergies are better understood and managed.
